BlackRock Institutional Trust’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $19.7M | Buy |
771,977
+14,337
| +2% | +$366K | ﹤0.01% | 1978 |
|
|
2016
Q3 | $27.4M | Buy |
757,640
+26,834
| +4% | +$971K | ﹤0.01% | 1662 |
|
|
2016
Q2 | $24.8M | Buy |
730,806
+84,161
| +13% | +$2.86M | ﹤0.01% | 1701 |
|
|
2016
Q1 | $17.1M | Buy |
646,645
+90,965
| +16% | +$2.4M | ﹤0.01% | 1919 |
|
|
2015
Q4 | $27.1M | Buy |
555,680
+92,970
| +20% | +$4.53M | ﹤0.01% | 1638 |
|
|
2015
Q3 | $11.5M | Buy |
462,710
+150,180
| +48% | +$3.74M | ﹤0.01% | 2193 |
|
|
2015
Q2 | $9.89M | Buy |
312,530
+20,249
| +7% | +$641K | ﹤0.01% | 2414 |
|
|
2015
Q1 | $11.1M | Buy |
292,281
+85,361
| +41% | +$3.25M | ﹤0.01% | 2332 |
|
|
2014
Q4 | $8.06M | Buy |
206,920
+36,524
| +21% | +$1.42M | ﹤0.01% | 2491 |
|
|
2014
Q3 | $5.15M | Sell |
170,396
-11,725
| -6% | -$355K | ﹤0.01% | 2676 |
|
|
2014
Q2 | $6.19M | Buy |
182,121
+101,121
| +125% | +$3.44M | ﹤0.01% | 2674 |
|
|
2014
Q1 | $2.8M | Sell |
81,000
-79,336
| -49% | -$2.74M | ﹤0.01% | 3021 |
|
|
2013
Q4 | $6.35M | Buy |
+160,336
| New | +$6.35M | ﹤0.01% | 2675 |
|